Usefulness of Proviral Load Measurement for Monitoring of Disease Activity in Individual Patients with Human T-Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis

References

• Al-Fahim A, Cabre P, et al (1999). Blood mononuclear cells in patients with HTLV-I-associated myelopathy: lym-phocytes are highly activated and adhesion to endothe-lial cells is increased. Cell Immuno1198: 1–10.
   Google Scholar
• Aye MM, Matsuoka E, et al (2000). Histopathological analy-sis of four autopsy cases of HTLV-I- associated myelopa-thy/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous sys-tem. Acta Neuropathol (Berl) 100: 245–252.
   PubMed Web of Science ®Google Scholar
• Furukawa Y, Yamashita M, et al (2000). Phylogenetic sub-groups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with dif-ferent risks for HTLV-I- associated myelopathy/tropical spastic paraparesis. J Infect Dis 182: 1343–1349.
   PubMed Web of Science ®Google Scholar
• Gessain A, Barin F, et al (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2: 407–410.
   PubMed Web of Science ®Google Scholar
• Hara H, Morita M, et al (1994). Detection of human T lym-photrophic virus type I (HTLV-I) proviral DNA and anal-ysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I- associated myelopathy/tropical spastic paraparesis. J Exp Med 180: 831–839.
   Google Scholar
• Hashimoto K, Higuchi I, et al (1998). Quantitative in situ PCR assay of HTLV-1 infected cells in peripheral blood lymphocytes of patients with ATL, HAM/TSP and asymptomatic carriers. J Neurol Sci 159: 67–72.
   PubMed Web of Science ®Google Scholar
• Ijichi S, Eiraku N, et al (1989). Activated T lymphocytes in cerebrospinal fluid of patients with HTLV-I-associated myelopathy (HAM/TSP). J Neuroimmunol 25: 251–254.
   Google Scholar
• Ijichi S, Izumo S, et al (1993). An autoaggressive process against bystander tissues in HTLV-I-infected individu-als: a possible pathomechanism of HAM/TSP. Med Hy-potheses 41: 542–547.
   Google Scholar
• Izumo S, Goto I, et al (1996). Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, random-ized, double-blind, controlled trial. Neurology 46: 1016–1021.
   PubMed Web of Science ®Google Scholar
• Izumo S, Umehara F, et al (1997). Neuropathology of HTLV-1-associated myelopathy (HAM/TSP). Leukemia 11: 82–84.
   Google Scholar
• Jeffery KJ, Siddiqui AA, et al (2000). The influence of HLA class I alleles and heterozygosity on the outcome of hu-man T cell lymphotropic virus type I infection. J Im-muno1165: 7278–7284.
   Google Scholar
• Jeffery KJ, Usuku K, et al (1999). HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Nati Acad Sci USA 96: 3848–3853.
   PubMed Web of Science ®Google Scholar
• Kambara C, Nakamura T, et al (1999). Vascular cell ad-hesion molecule-1-mediated matrix metalloproteinase-2 induction in peripheral blood T cells is up-regulated in patients with HTLV- I-associated myelopathy. J Neu-roimmunol 99: 242–247.
   Google Scholar
• Kubota R, Fujiyoshi T, et al (1993). Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. J Neuroimmunol 42: 147–154.
   Google Scholar
• Kubota R, Umehara F, et al (1994). HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J Neuroimmunol 53: 23–29.
   PubMed Web of Science ®Google Scholar
• Matsuo H, Nakamura T, et al (1989). Long-term-follow-up of immunomodulation in treatment of HTLV-I-associated myelopathy. Lancet 1: 790.
   Google Scholar
• Matsuoka E, Takenouchi N, et al (1998). Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy/tropical spastic paraparesis: double staining of i=unohisto-chemistry and polymerase chain reaction in situ hy-bridization. Acta Neuropathol (Bed) 96: 340–346.
   PubMed Web of Science ®Google Scholar
• Matsuoka E, Usuku K, et al (2000). CD44 splice variant in-volvement in the chronic inflammatory disease of the spinal cord: HAM/TSP. J Neuroimmuno1102: 1–7.
   Google Scholar
• Mori M, Kinoshita K, et al (1988). Activated T-lymphocytes with polyclonal ga=opathy in patients with human T-lymphotropic virus type I-associated myelopathy. Ann Neurol 24: 280–282.
   Google Scholar
• Moritoyo T, Izumo S, et al (1999). Detection of human T-lymphotropic virus type I p4Otax protein in cerebro-spinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/ tropical spastic paraparesis. J NeuroVirol 5: 241–248.
   Web of Science ®Google Scholar
• Moritoyo T, Reinhart TA, et al (1996). T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol 40: 84–90.
   PubMedGoogle Scholar
• Nagai M, Usuku K, et al (1998). Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J NeuroVirol 4: 586–593.
   PubMed Web of Science ®Google Scholar
• Nagai M, Yamano Y, et al (2001). Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP. Ann Neurol 50: 807–812.
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Izumo S, et al (1995). HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J NeuroVirol 1: 50–61.
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Nakahara K, et al (1996). Therapeutic tri-als in 200 patients with HTLV-I-associated myelopa-thy/tropical spastic paraparesis. J NeuroVirol 2: 345–355.
   PubMed Web of Science ®Google Scholar
• Nakamura T (2000). Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Med 32: 600–607.
   Web of Science ®Google Scholar
• Nakane S, Shirabe S, et al (2000). Comparative molec-ular analysis of HTLV-I proviral DNA in HTLV-I infected members of a family with a discordant HTLV-I-associated myelopathy in monozygotic twins. J Neuro-Virol 6: 275–283.
   Web of Science ®Google Scholar
• Osame M, Igata A, et al (1990). HTLV-I-associated myelopa-thy (HAM). Treatment trials, retrospective survey, and clinical and laboratory findings. Hematol Rev 3: 271–284.
   Google Scholar
• Osame M, Usuku K, et al (1986). HTLV-I-associated myelopathy, a new clinical entity [letter]. Lancet 1: 1031–1032.
   PubMed Web of Science ®Google Scholar
• Perelson AS, Neumann AU, et al (1996). HIV-1 dynam-ics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582–1586.
   PubMed Web of Science ®Google Scholar
• Renjifo B, Chou K, et al (1996). Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome. J Acquir Immune Defic Syndr Hum Retrovirol 13: 146–153.
   PubMedGoogle Scholar
• Romero IA, Prevost MC, et al (2000). Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral en-try into the central nervous system. J Virol 74: 6021–6030.
   PubMed Web of Science ®Google Scholar
• Takenouchi N, Matsuoka E, et al (1999). Molecular patho-logic analysis of the tonsil in HTLV-I-infected individu-als. J Acquir Immune Defic Syndr 22: 200–207.
   Google Scholar
• Tateno M (1987). Rat lymphoid cell lines producing human T cell leukemia virus-I. Hokkaido Igaku Zasshi 62: 74–81.
   Google Scholar
• Umehara F, Izumo S, et al (1996). Expression of adhe-sion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol (Bed) 91: 343–350.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Miyoshi I, et al (1982). Isolation and charac-terization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79: 2031–2035.
   Google Scholar